Jim Cramer Highlights "Takeover Interest" in Revolution Medicines

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the stocks Jim Cramer talked about, along with market froth. Cramer highlighted that there is a takeover interest in the company, as he commented:

Of the 32 stocks that made our froth list, seven of them were biotechs, and four of them have more than doubled. Some of these moves are easy to understand. There’s Revolution Medicines. It’s up nearly 46% after reportedly drawing takeover interest from… Merck… That could be a winner. Others have had strong clinical trial results. I like that. But again, biotech is not a good leadership group. This is a boom and bust business where gains can disappear just as quickly as they materialize. At that JPMorgan Healthcare conference I went to… I got a feeling that all sorts of biotechs were raising money here and rallying to pretty incredible valuations, often based on nothing more than a press release. That’s froth.

Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage oncology company developing targeted therapies for RAS-driven cancers. RAS refers to a family of genes that produce proteins controlling cell growth and division.

While we acknowledge the potential of RVMD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.